-
Sector Analysis
NewPolycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Report Overview Polycystic Ovarian Syndrome (PCOS) is a complex condition characterized by elevated androgen levels, menstrual irregularities, and/or small cysts on one or both ovaries. It stands as the most prevalent hormonal disorder affecting females of reproductive age. Genetic and environmental factors are responsible for the etiology of this condition. Unhealthy lifestyle choices, dietary habits, or exposure to infectious agents tend to increase the risk of developing PCOS. Key Mechanisms of Action...
-
Sector Analysis
NewFemale Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Female Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Report Overview Female sexual dysfunction (FSD) is an umbrella term that encompasses disorders of sexual desire, orgasm, arousal, and sexual pain that result in significant personal distress. FSD is a multifactorial, progressive problem that can occur at any stage of life. It is a complex neurovascular phenomenon that is under the control of psychological, neurovascular, and hormonal factors. Key Mechanisms of Action (Marketed) · Receptor Agonist · Enzyme Inhibitor · Receptor Antagonist...
-
Product Insights
NewEndometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Endometriosis Clinical Trial Report Overview A total of 812 Endometriosis clinical trials were conducted as of February 2024. The Endometriosis clinical trial report provides a comprehensive understanding of the Endometriosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · North America · Europe · Asia-Pacific · ...
-
Sector Analysis
Premature Labor (PL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Premature Labor (PL) Marketed and Pipeline Drugs Report Overview Premature/preterm labor (PL) is labor occurring after 20 and before 37 weeks gestation. Premature deliveries cause more than half of long-term morbidity and 75% of perinatal mortality. Premature labor is diagnosed primarily by history and symptoms. Symptoms of preterm labor include regular contractions before term gestational age associated with cervical change, pelvic pressure, menstrual-like cramps, watery vaginal discharge, and lower back pain. Although lower back pain is present in normal pregnancy as well,...
-
Product Insights
Endometriosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Endometriosis - Drugs In Development, 2023’, provides an overview of the Endometriosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endometriosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Female Contraception – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Contraception - Drugs In Development, 2023’, provides an overview of the Female Contraception pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Post Partum Depression (Maternal Depression / Postnatal Depression) – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Partum Depression (Maternal Depression / Postnatal Depression) - Drugs In Development, 2023’, provides an overview of the Post Partum Depression (Maternal Depression / Postnatal Depression) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Partum Depression (Maternal Depression / Postnatal Depression), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Premature Labor (Tocolysis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Drugs In Development, 2023’, provides an overview of the Premature Labor (Tocolysis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Polycystic Ovarian Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Drugs In Development, 2023’, provides an overview of the Polycystic Ovarian Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polycystic Ovarian Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) – Drugs In Development, 2023
Global Markets Direct’s, ‘Vasomotor Symptoms of Menopause (Hot Flashes) - Drugs In Development, 2023’, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...